Moody National Bank Trust Division Immuno Gen, Inc. Transaction History

Moody National Bank Trust Division

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$3.67 - $4.92 $36,153 - $48,466	9,851 Added 27.36%	45,860 $176,000
Q4 2022 Jan 11, 2023	BUY	$4.55 - $6.31 $101,901 - $141,318	22,396 Added 164.52%	36,009 $179,000
Q3 2022 Oct 05, 2022	BUY	$4.48 - $6.47 $60,986 - $88,076	13,613 New	13,613 $65,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.